Sarepta Therapeutics has entered a Cooperative Research and Development Agreement (CRADA) with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) for potential Covid-19 treatments. Under the agreement, the parties will use Sarepta’s proprietary phosphorodiamidate morpholino oligomer (PMO) platform. The company will be responsible for multiple peptide-conjugated PMO (PPMO) constructs based on genetic sequencing of SARS-CoV-2. The USAMRIID will evaluate the constructs for their potential to treat Covid-19.
The Canadian Government has selected PAE to arrange the delivery of up to ten 100-bed mobile health units. The company was chosen through its SNC-Lavalin PAE joint venture. SNC-Lavalin PAE president and general manager Robert Spencer said: “In an enduring partnership supporting the Canadian Armed Forces on deployed operations in Bosnia, Kabul and Kandahar in Afghanistan, and currently in Iraq and Kuwait, it is an honour and privilege to leverage the significant experience, capabilities and resources of SNC-Lavalin and PAE in serving Canadians at home.”
Sri Lankan President Gotabaya Rajapaksa has appointed a new task force to focus and ensure the health security at military camps. The newly established special Presidential Task Force will be headed by the Western Province Governor Marshal of the Air Force Roshan Gunatileke. Special attention will be given to those security forces personnel who act closely with the Covid-19 infected and engaged in quarantine activities.
The Chinese People’s Liberation Army (PLA) has provided assistance to the Lebanese military to help combat Covid-19 pandemic, reported Xinhua. The support, which was provided in response to a request from the Lebanese military, was approved by the Central Military Commission. It included materials such as medical masks and protective gowns to help prevent and control Covid-19. The PLA had supplied protective gowns and nucleic acid testing kits to the Cambodian military on Saturday.